Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma
暂无分享,去创建一个
[1] S. Behura,et al. Comparative evaluation of immunohistochemical expression of MCM2 and Ki67 in oral epithelial dysplasia and oral squamous cell carcinoma , 2022, Journal of cancer research and therapeutics.
[2] Zhenying Zhao,et al. Epidemiological Trends of Head and Neck Cancer: A Population-Based Study , 2021, BioMed research international.
[3] Cun-Yu Wang,et al. Targeting cancer stem cells in squamous cell carcinoma , 2019, Precision clinical medicine.
[4] Xi Yang,et al. Cancer stem cell biomarkers for head and neck squamous cell carcinoma: A bioinformatic analysis. , 2018, Oncology reports.
[5] S. Irani,et al. Expression of vimentin and CD44 in mucoepidermoid carcinoma: A role in tumor growth , 2018, Indian journal of dental research : official publication of Indian Society for Dental Research.
[6] Cun-Yu Wang,et al. Targeting BMI1+ Cancer Stem Cells Overcomes Chemoresistance and Inhibits Metastases in Squamous Cell Carcinoma. , 2017, Cell stem cell.
[7] Priyanka Chevour,et al. Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition , 2017, Molecular carcinogenesis.
[8] S. Behura,et al. Cancer stem cell markers, SOX 2 and OCT 4 in ameloblastoma and keratocystic odontogenic tumor: An immunohistochemical study , 2017 .
[9] H. M. Jamil,et al. STEM CELL AND CANCER STEM CELL: A Tale of Two Cells - , 2016 .
[10] M. Chou,et al. Targeting CD133 in the enhancement of chemosensitivity in oral squamous cell carcinoma–derived side population cancer stem cells , 2016, Head & neck.
[11] N. Lindquist,et al. The Role of Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma and Its Clinical Implications , 2016 .
[12] Young-Hoon Kang,et al. Positive expression of NANOG, mutant p53, and CD44 is directly associated with clinicopathological features and poor prognosis of oral squamous cell carcinoma , 2015, BMC oral health.
[13] L. Dionne,et al. Head and Neck Cancer Stem Cells , 2015, Journal of dental research.
[14] S. Behura,et al. Human Papilloma Virus (HPV) Induced Head & Neck Squamous Cell Carcinoma: A Comprehensive Retrospect. , 2015, Journal of clinical and diagnostic research : JCDR.
[15] J. Utikal,et al. SOX2 and cancer: current research and its implications in the clinic , 2014, Clinical and Translational Medicine.
[16] H. Ishii,et al. CD10 as a novel marker of therapeutic resistance and cancer stem cells in head and neck squamous cell carcinoma , 2014, British Journal of Cancer.
[17] J. Gutkind,et al. Impairing squamous differentiation by Klf4 deletion is sufficient to initiate tongue carcinoma development upon K-Ras activation in mice. , 2014, Carcinogenesis.
[18] Yu-Chao Chang,et al. Oct4 Mediates Tumor Initiating Properties in Oral Squamous Cell Carcinomas through the Regulation of Epithelial-Mesenchymal Transition , 2014, PloS one.
[19] C. Farah,et al. Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma , 2013, Stem cells international.
[20] M. Grimm,et al. ABCB5 expression and cancer stem cell hypothesis in oral squamous cell carcinoma. , 2012, European journal of cancer.
[21] E. Choi,et al. Overexpression of c-Met promotes invasion and metastasis of small oral tongue carcinoma. , 2012, Oral oncology.
[22] W. Liu,et al. Two stem cell markers, ATP‐binding cassette, G2 subfamily (ABCG2) and BMI‐1, predict the transformation of oral leukoplakia to cancer , 2012, Cancer.
[23] B. Wollenberg,et al. Stem cells in squamous head and neck cancer. , 2012, Critical reviews in oncology/hematology.
[24] A. Giatromanolaki,et al. Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head–neck cancer , 2012, British Journal of Cancer.
[25] L. Vermeulen,et al. Cancer stem cell niche: the place to be. , 2011, Cancer research.
[26] M. Hummel,et al. Evidence for Epithelial-Mesenchymal Transition in Cancer Stem Cells of Head and Neck Squamous Cell Carcinoma , 2011, PloS one.
[27] T. Kang,et al. Prognostic significance of Oct4 and Sox2 expression in hypopharyngeal squamous cell carcinoma , 2010, Journal of Translational Medicine.
[28] J. Shay,et al. Telomeres and telomerase in normal and cancer stem cells , 2010, FEBS letters.
[29] C. Farah,et al. Oral mucosal malignancy and potentially malignant lesions: an update on the epidemiology, risk factors, diagnosis and management. , 2010, Australian dental journal.
[30] Y. Yen,et al. A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. , 2010, Cancer letters.
[31] C. Haglund,et al. Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue , 2010, British Journal of Cancer.
[32] R. Tuan,et al. Regulation of stemness and stem cell niche of mesenchymal stem cells: Implications in tumorigenesis and metastasis , 2010, Journal of cellular physiology.
[33] Z. Chen. The Cancer Stem Cell Concept in Progression of Head and Neck Cancer , 2009, Journal of oncology.
[34] L. Ailles,et al. Cancer stem cells in head and neck squamous cell cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] P. Dirks,et al. Cancer stem cells: at the headwaters of tumor development. , 2007, Annual review of pathology.
[36] Linheng Li,et al. Normal stem cells and cancer stem cells: the niche matters. , 2006, Cancer research.
[37] J. Tong,et al. Expression of SOX 2 in oral squamous cell carcinoma and the association with lymph node metastasis ( Review ) , 2016 .
[38] M. Vaidya,et al. Prognostic role of Oct4, CD44 and c-Myc in radio–chemo-resistant oral cancer patients and their tumourigenic potential in immunodeficient mice , 2015, Clinical Oral Investigations.
[39] M. Chou,et al. Sox2 expression involvement in the oncogenicity and radiochemoresistance of oral cancer stem cells. , 2015, Oral oncology.
[40] L. Allen. Stem cells. , 2003, The New England journal of medicine.